# Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

> **NCT00005000** · PHASE4 · UNKNOWN · sponsor: **Agouron Pharmaceuticals** · enrollment: 200 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Nelfinavir mesylate
- **DRUG:** Efavirenz
- **DRUG:** Lamivudine
- **DRUG:** Keyhole-Limpet Hemocyanin
- **DRUG:** Stavudine
- **DRUG:** Zidovudine
- **DRUG:** Didanosine

## Key facts

- **NCT ID:** NCT00005000
- **Lead sponsor:** Agouron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1999-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 200 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005000, "Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00005000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*